History Of Melanoma

<!-- @page { size: 21cm 29.7cm; margin: 2cm }melanocyte survival.
P { margin-bottom: 0.21cm } -->It is often difficult to design drugs that interfere
Although melanoma is not a new disease,with transcription factors, but perhaps new drugs
evidence for its occurrence in antiquity is ratherwill be discovered that can impede some reaction
scarce. However, one example lies in a 1960sin the pathway upstream of MITF. Studies of
examination of nine Peruvian Inca mummies,chromatin structure also promise to shed light on
radiocarbon dated to be approximately 2400transcriptional regulation in melanoma cells. It has
years old, which showed apparent signs oflong been assumed that nucleosomes are
melanoma: melanotic masses in the skin andpositioned randomly on DNA.
diffuse metastases to the bones.But murine studies of genes involved in melanin
John Hunter is reported to be the first to operateproduction now suggest that nucleosomes are
on metastatic melanoma in 1787. Although notstereotypically positioned on DNA. When a gene is
knowing precisely what it was, he described it asundergoing transcription, its transcription start site
a "cancerous fungous excrescence". The excisedis almost always nucleosome-free. When the gene
tumor was preserved in the Hunterian Museum ofis silent, however, nucleosomes often block the
the Royal College of Surgeons of England. It wastranscriptional start site, suggesting that
not until 1968 that microscopic examination of thenucleosome position may play a role in gene
specimen revealed it to be an example ofregulation.
metastatic melanoma.Given the fact that melanin helps protect skin cells
The French physician René Laennec was thefrom UV-induced damage, new melanoma
first to describe melanoma as a disease entity. Hisprevention strategies could involve attempts to
report was initially presented during a lecture forinduce melanin synthesis in individuals who would
the Faculté de Médecine de Paris in 1804 andotherwise get sunburns. Redheads, for example,
then published as a bulletin in 1806. The firstdo not tan because they have MC1R mutations.
English language report of melanoma wasPerhaps such a strategy will eventually be used to
presented by an English general practitioner fromprotect humans from melanoma.
Stourbridge, William Norris in 1820.NeviCurative is a powerful all natural topical
In his later work in 1857 he remarked that theretreatment proven to eliminate and defeat moles
is a familial predisposition for development ofor nevi. The pharmacological strength of
melanoma. The first formal acknowledgment ofNeviCurative provides effective elimination of
advanced melanoma as untreatable came frommoles without scarring, tissue damage, or
Samuel Cooper in 1840. He stated that the onlyrecurrence. The treatment is painless and delivers
chance for benefit depends upon the earlyprofound results in the elimination of moles,
removal of the disease. More than one and a halfreturning skin tissue back to its original state.
centuries later this situation remains largelyRecent clinical trials have established the ability of
unchanged.the active constituents in NeviCurative to
One important pathway in melanin synthesiseffectively eradicate skin moles and impair the
involves the transcription factor MITF. The MITFgrowth of human melanoma cells. NeviCurative
gene is highly conserved and is found in people,has therefore been shown to eliminate even the
mice, birds, and even fish. MITF production ismost stubborn moles, regardless of their location
regulated via a fairly straightforward pathway. UVon the body, even when other treatments have
radiation causes increased expression offailed.
transcription factor p53 in keratinocytes.NeviCurative is well-known for its antioxidant
P53 causes these cells to produce melanocyteproperties. It is comprised of certified organic
stimulating hormone, which binds to melanocortin 1medicinal plant extracts, which have demonstrated
receptors (MC1R) on melanocytes. Ligand-bindingtheir ability to eradicate melanomas and skin
at MC1R receptors activates adenylate cyclases,tumors in laboratory tests. These extracts have a
which produce cAMP, which activates CREB, whichremarkable array of pharmacological and
promote MITF expression. The targets of MITFbiochemical properties, which are highly effective
include p16 and Bcl2, a gene essential toin eradicating moles.